Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: Newron weitet internationale Studie zur Untersuchung der Krankheitslast von Rett-Syndrom auf Europa und Australien aus
DGAP-News: Newron weitet internationale Studie zur Untersuchung der Krankheitslast von Rett-Syndrom auf Europa und Australien aus
DGAP-News: Newron weitet internationale Studie zur Untersuchung der Krankheitslast von Rett-Syndrom auf Europa und Australien aus
eqs_de 
0 17.02.20
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
eqs_en 
0 14.02.20
DGAP-News: Burcon NutraScience Corp.: Burcon nimmt Handel am OTCQB(R) Venture Market in den USA auf
DGAP-News: Burcon NutraScience Corp.: Burcon nimmt Handel am OTCQB(R) Venture Market in den USA auf
DGAP-News: Burcon NutraScience Corp.: Burcon nimmt Handel am OTCQB(R) Venture Market in den USA auf
eqs_de 
0 13.02.20
DGAP-News: Burcon NutraScience Corp.: Burcon Commences Trading on the OTCQB(R) Venture Market in the U.S.
DGAP-News: Burcon NutraScience Corp.: Burcon Commences Trading on the OTCQB(R) Venture Market in the U.S.
DGAP-News: Burcon NutraScience Corp.: Burcon Commences Trading on the OTCQB(R) Venture Market in the U.S.
eqs_en 
0 13.02.20
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
eqs_en 
0 13.02.20
DGAP-News: 4SC to present at the World Congress of Cutaneous Lymphomas in Barcelona, Spain
DGAP-News: 4SC to present at the World Congress of Cutaneous Lymphomas in Barcelona, Spain
DGAP-News: 4SC to present at the World Congress of Cutaneous Lymphomas in Barcelona, Spain
eqs_en 
0 12.02.20
DGAP-News: 4SC präsentiert auf dem World Congress of Cutaneous Lymphomas in Barcelona, Spanien
DGAP-News: 4SC präsentiert auf dem World Congress of Cutaneous Lymphomas in Barcelona, Spanien
DGAP-News: 4SC präsentiert auf dem World Congress of Cutaneous Lymphomas in Barcelona, Spanien
eqs_de 
0 12.02.20
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
eqs_en 
0 11.02.20
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
eqs_en 
0 10.02.20
DGAP-News: CO.DON AG erweitert ihre Produktpalette um Auftragsherstellung
DGAP-News: CO.DON AG erweitert ihre Produktpalette um Auftragsherstellung
DGAP-News: CO.DON AG erweitert ihre Produktpalette um Auftragsherstellung
eqs_de 
0 10.02.20
DGAP-News: CO.DON AG adds contract manufacturing to its product portfolio
DGAP-News: CO.DON AG adds contract manufacturing to its product portfolio
DGAP-News: CO.DON AG adds contract manufacturing to its product portfolio
eqs_en 
0 10.02.20
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
eqs_en 
0 07.02.20
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
eqs_en 
0 06.02.20
Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
Hardman & Co Research: Tissue Regenix (TRX): Restructured to satisfy product demand
eqs_en 
0 06.02.20
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
eqs_en 
0 05.02.20
Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult
Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult
Hardman & Co Research: genedrive plc (GDR): Western market progress but developing markets difficult
eqs_en 
0 05.02.20
DGAP-News: Formycon informiert über aktuellen Status im Zulassungsprozess des Lucentis(R)* Biosimilar-Kandidaten FYB201
DGAP-News: Formycon informiert über aktuellen Status im Zulassungsprozess des Lucentis(R)* Biosimilar-Kandidaten FYB201
DGAP-News: Formycon informiert über aktuellen Status im Zulassungsprozess des Lucentis(R)* Biosimilar-Kandidaten FYB201
eqs_de 
0 04.02.20
DGAP-News: Formycon informs about the current Status of the BLA Review Process of the Lucentis(R)* Biosimilar Candidate FYB201
DGAP-News: Formycon informs about the current Status of the BLA Review Process of the Lucentis(R)* Biosimilar Candidate FYB201
DGAP-News: Formycon informs about the current Status of the BLA Review Process of the Lucentis(R)* Biosimilar Candidate FYB201
eqs_en 
0 04.02.20
DGAP-News: MorphoSys Initiiert Expanded Access Program für Tafasitamab in den USA: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys Initiiert Expanded Access Program für Tafasitamab in den USA
DGAP-News: MorphoSys Initiiert Expanded Access Program für Tafasitamab in den USA
eqs_de 
0 04.02.20
DGAP-News: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.
DGAP-News: MorphoSys Initiates Expanded Access Program for Tafasitamab in the U.S.
eqs_en 
0 04.02.20
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
eqs_en 
0 04.02.20
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2019 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2019 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2019 (IFRS)
eqs_en 
0 04.02.20
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
Form 8.3 - The Vanguard Group, Inc.: AbbVie plc
eqs_en 
0 03.02.20
DGAP-News: CO.DON AG: CO.DON AG launcht neue Firmenwebsite
DGAP-News: CO.DON AG: CO.DON AG launcht neue Firmenwebsite
DGAP-News: CO.DON AG: CO.DON AG launcht neue Firmenwebsite
eqs_de 
0 03.02.20
DGAP-News: CO.DON AG: CO.DON AG launches new website
DGAP-News: CO.DON AG: CO.DON AG launches new website
DGAP-News: CO.DON AG: CO.DON AG launches new website
eqs_en 
0 03.02.20